{"id":6051,"date":"2023-05-24T06:30:00","date_gmt":"2023-05-24T06:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-releases-the-annual-report-for-2022\/"},"modified":"2023-05-24T06:30:00","modified_gmt":"2023-05-24T06:30:00","slug":"realheart-releases-the-annual-report-for-2022","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-releases-the-annual-report-for-2022\/","title":{"rendered":"Realheart Releases the Annual Report for 2022"},"content":{"rendered":"
Press Release, 24 May 2023<\/strong><\/div>\n

Today, Realheart publishes the annual report for 2022. In addition to the regular Swedish version, a designed version is also released containing reports, collaborations and milestones during the year.<\/span><\/span><\/p>\n

The annual report including the auditor's report and the designed English version can be found at\u00a0www.realheart.se<\/a>\u00a0and as attachments in this press release.\u00a0<\/span><\/span><\/p>\n

\n

For more information please contact:<\/span><\/span><\/strong><\/span><\/p>\n

Ina Laura Perkins, CEO<\/span><\/span><\/p>\n

Phone: +46(0)70 406 49 21\u00a0<\/span><\/span><\/p>\n

E-mail: inalaura.perkins@realheart.se<\/span><\/span><\/p>\n

Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se<\/a><\/p>\n<\/div>\n

\n

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart<\/em><\/span><\/span>\u00ae<\/span><\/span><\/span><\/em> TAH has a patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation.\u00a0<\/em><\/span><\/span>A unique concept in the medical technology world.<\/span><\/span><\/span><\/em><\/p>\n<\/div>\n